Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade

Prognosis of glioblastoma remains dismal, underscoring the need for novel therapies. Immunotherapy is generating promising results, but requires combination strategies to unlock its full potential. We investigated the immunomodulatory capacities of poly(I:C) on primary human glioblastoma cells and i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: De Waele, Jorrit, Marcq, Elly, Van Audenaerde, Jonas RM, Van Loenhout, Jinthe, Deben, Christophe, Zwaenepoel, Karen, Van de Kelft, Erik, Van der Planken, David, Menovsky, Tomas, Van den Bergh, Johan MJ, Willemen, Yannick, Pauwels, Patrick, Berneman, Zwi N, Lardon, Filip, Peeters, Marc, Wouters, An, Smits, Evelien LJ
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5790389/
https://ncbi.nlm.nih.gov/pubmed/29399410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1407899
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars